Home Other Building Blocks 1390637-82-7
1390637-82-7,MFCD22417344
Catalog No.:AA009E8F

1390637-82-7 | PF-04981517

Pack Size
Purity
Availability
Price(USD)
Quantity
  
5mg
≥98%
in stock  
$123.00   $86.00
- +
10mg
≥98%
in stock  
$230.00   $161.00
- +
25mg
≥98%
in stock  
$542.00   $379.00
- +
50mg
≥98%
in stock  
$959.00   $671.00
- +
100mg
98% by HPLC
in stock  
$1,913.00   $1,339.00
- +
500mg
98% by HPLC
in stock  
$6,035.00   $4,224.00
- +
1000mg
98% by HPLC
in stock  
$9,618.00   $6,733.00
- +
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
  • Request for Quotation
  • Download SDS
  • Technical Information
  • Properties
  • Downstream Synthesis Route
  • Literature
Technical Information
Catalog Number:
AA009E8F
Chemical Name:
PF-04981517
CAS Number:
1390637-82-7
Molecular Formula:
C26H32N8
Molecular Weight:
456.5859
MDL Number:
MFCD22417344
SMILES:
Cc1ccc(cc1)c1n(C)ncc1c1nn(c2c1c(ncn2)N1CC[C@@H](C1)N1CCCCC1)C
Properties
Computed Properties
 
Complexity:
678  
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
1  
Heavy Atom Count:
34  
Hydrogen Bond Acceptor Count:
6  
Rotatable Bond Count:
4  
XLogP3:
3.7  

Downstream Synthesis Route

[1]CurrentPatentAssignee:PFIZERINC-WO2012/168817,2012,A1Locationinpatent:Page/Pagecolumn47-48

1-methyl-5-(p-tolyl)-1H-pyrazole-4-carbaldehyde 
  1390637-82-7 

[1]CurrentPatentAssignee:PFIZERINC-WO2012/168817,2012,A1

[1]CurrentPatentAssignee:PFIZERINC-WO2012/168817,2012,A1

[1]CurrentPatentAssignee:PFIZERINC-WO2012/168817,2012,A1

[1]CurrentPatentAssignee:PFIZERINC-WO2012/168817,2012,A1

Literature

Title: Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs.

Journal: Drug metabolism and disposition: the biological fate of chemicals 20120901

Title: Robert L Walsky, et al. Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugs. Drug Metab Dispos. 2012 Sep;40(9):1686-97.

Quotation Request
Company Name:
*
Contact Person:
*
Email:
*
Quantity Required:
*
Country:
Additional Info:
SDS
Related Products of 1390637-82-7
Tags:1390637-82-7 Molecular Formula|1390637-82-7 MDL|1390637-82-7 SMILES|1390637-82-7 PF-04981517